研究業績
Achievement

2023年の研究業績

1. 原著

  1. Fujiyama N, Tasaki M, Harada H, Tsutahara K, Matsumoto A, Kamijo Y, Toyoda M, Iwami D, Inui M, Shirakawa H, Sugimura J, Saito M, Hotta K, Okumi M, Saito K, Watarai Y, Hidaka Y, Ohtani K, Inoue N, Wakamiya N, Habuchi T, Satoh S; Japanese Post-kidney Transplant TMA Support Team. Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry. Clin Exp Nephrol. 2023 Dec; 27(12):1010-1020. doi: 10.1007/s10157-023-02391-5. PMID: 37634218
  2. Nishioka, T., Katayama, K., Kumegawa, S., Isono, K., Baba, T., Tsujimoto, H., Yamada, G., Inoue, N., and Asamura, S. Increased infiltration of CD4+ T cell in the complement deficient lymphedema model. BMC Immunology 2023 Nov 8, 24: 42 doi: 10.1186/s12865-023-00580-1. PMID: 37940849
  3. Miyamoto, K., Minamino, M., Kuwahara, M., Tsujimoto, H., Ohtani, K., Wakamiya, N., Katayama, K., Inoue N., and Ito, H. Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders. Front. Immunol 2023, Mar 3, 14:1090548. Doi: 10.3389/fimmu.2023.1090548. PMID: 36936980
  4. Katayama, K., Zheng, Y., Inoue, N. Rac is required for the survival of cortical neurons. Exp Neurol. 2023 Mar;361:114316. doi: 10.1016/j.expneurol.2022.114316.

2. 総説

英文

和文

  1. 植田康隆、井上徳光:溶血性貧血 医学のあゆみ 2023; 287(10):749-756
トップへ